Annual Cash & Cash Equivalents:
$204.14M-$78.43M(-27.76%)Summary
- As of today, CRL annual cash & cash equivalents is $204.14 million, with the most recent change of -$78.43 million (-27.76%) on December 31, 2024.
- During the last 3 years, CRL annual cash & cash equivalents has fallen by -$42.16 million (-17.12%).
- CRL annual cash & cash equivalents is now -27.76% below its all-time high of $282.57 million, reached on December 31, 2023.
Performance
CRL Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$207.67M+$24.45M(+13.34%)Summary
- As of today, CRL quarterly cash & cash equivalents is $207.67 million, with the most recent change of +$24.45 million (+13.34%) on September 27, 2025.
- Over the past year, CRL quarterly cash & cash equivalents has dropped by -$2.82 million (-1.34%).
- CRL quarterly cash & cash equivalents is now -55.86% below its all-time high of $470.45 million, reached on March 27, 2021.
Performance
CRL Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRL Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -27.8% | -1.3% |
| 3Y3 Years | -17.1% | +5.9% |
| 5Y5 Years | -14.7% | -15.9% |
CRL Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -27.8% | at low | -38.4% | +26.8% |
| 5Y | 5-Year | -27.8% | at low | -55.9% | +26.8% |
| All-Time | All-Time | -27.8% | +722.8% | -55.9% | +1025.1% |
CRL Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $207.67M(+13.3%) |
| Jun 2025 | - | $183.22M(-20.4%) |
| Mar 2025 | - | $230.26M(+12.8%) |
| Dec 2024 | $204.14M(-27.8%) | $204.14M(-3.0%) |
| Sep 2024 | - | $210.49M(+17.2%) |
| Jun 2024 | - | $179.54M(-46.8%) |
| Mar 2024 | - | $337.37M(+19.4%) |
| Dec 2023 | $282.57M(+17.2%) | - |
| Dec 2023 | - | $282.57M(+72.6%) |
| Sep 2023 | - | $163.76M(-21.1%) |
| Jun 2023 | - | $207.58M(-0.1%) |
| Mar 2023 | - | $207.75M(-13.8%) |
| Dec 2022 | $241.10M(-2.1%) | $241.10M(+23.0%) |
| Sep 2022 | - | $196.03M(-5.4%) |
| Jun 2022 | - | $207.13M(-14.9%) |
| Mar 2022 | - | $243.35M(-1.2%) |
| Dec 2021 | $246.30M(+5.9%) | $246.30M(+13.1%) |
| Sep 2021 | - | $217.84M(-4.1%) |
| Jun 2021 | - | $227.12M(-51.7%) |
| Mar 2021 | - | $470.45M(+102.3%) |
| Dec 2020 | $232.52M(-2.9%) | $232.52M(-5.8%) |
| Sep 2020 | - | $246.81M(-38.8%) |
| Jun 2020 | - | $403.41M(+7.9%) |
| Mar 2020 | - | $373.81M(+56.2%) |
| Dec 2019 | $239.39M(+21.6%) | $239.39M(+44.1%) |
| Sep 2019 | - | $166.15M(-17.7%) |
| Jun 2019 | - | $201.97M(+58.1%) |
| Mar 2019 | - | $127.71M(-35.1%) |
| Dec 2018 | $196.79M(+2.0%) | $196.79M(+36.2%) |
| Sep 2018 | - | $144.53M(-25.4%) |
| Jun 2018 | - | $193.80M(+1.5%) |
| Mar 2018 | - | $190.92M(-1.0%) |
| Dec 2017 | $192.88M(+58.2%) | $192.88M(+24.8%) |
| Sep 2017 | - | $154.56M(+10.0%) |
| Jun 2017 | - | $140.51M(+3.4%) |
| Mar 2017 | - | $135.93M(+11.5%) |
| Dec 2016 | $121.93M(-12.1%) | $121.93M(+6.9%) |
| Sep 2016 | - | $114.03M(-36.7%) |
| Jun 2016 | - | $180.19M(+2.2%) |
| Mar 2016 | - | $176.38M(+27.1%) |
| Dec 2015 | $138.73M(-22.4%) | $138.73M(+48.8%) |
| Sep 2015 | - | $93.23M(-44.8%) |
| Jun 2015 | - | $168.98M(+0.2%) |
| Mar 2015 | - | $168.68M(-5.6%) |
| Dec 2014 | $178.74M(+6.8%) | $178.74M(+20.3%) |
| Sep 2014 | - | $148.62M(+12.3%) |
| Jun 2014 | - | $132.32M(-27.0%) |
| Mar 2014 | - | $181.31M(+8.4%) |
| Dec 2013 | $167.33M | $167.33M(+18.0%) |
| Sep 2013 | - | $141.77M(+17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $120.68M(+12.3%) |
| Mar 2013 | - | $107.50M(-7.9%) |
| Dec 2012 | $116.69M(+56.7%) | $116.69M(+29.9%) |
| Sep 2012 | - | $89.81M(+8.3%) |
| Jun 2012 | - | $82.93M(+23.0%) |
| Mar 2012 | - | $67.40M(-9.5%) |
| Dec 2011 | $74.49M(-60.6%) | $74.49M(-15.0%) |
| Sep 2011 | - | $87.64M(-44.5%) |
| Jun 2011 | - | $157.84M(-9.0%) |
| Mar 2011 | - | $173.51M(-8.3%) |
| Dec 2010 | $189.22M(-20.9%) | $189.22M(+24.6%) |
| Sep 2010 | - | $151.90M(-35.8%) |
| Jun 2010 | - | $236.72M(+1.1%) |
| Mar 2010 | - | $234.18M(-2.1%) |
| Dec 2009 | $239.25M(-2.9%) | $239.25M(+20.0%) |
| Sep 2009 | - | $199.37M(-4.2%) |
| Jun 2009 | - | $208.04M(-0.4%) |
| Mar 2009 | - | $208.92M(-15.2%) |
| Dec 2008 | $246.32M(+1.0%) | $246.32M(+14.0%) |
| Sep 2008 | - | $216.07M(-18.7%) |
| Jun 2008 | - | $265.73M(+5.7%) |
| Mar 2008 | - | $251.48M(+3.1%) |
| Dec 2007 | $243.90M(+33.4%) | $243.90M(+28.3%) |
| Sep 2007 | - | $190.09M(+14.9%) |
| Jun 2007 | - | $165.47M(+15.3%) |
| Mar 2007 | - | $143.46M(-28.5%) |
| Dec 2006 | $182.83M(-13.5%) | - |
| Jun 2006 | - | $200.74M(+90.6%) |
| Mar 2006 | - | $105.30M(-51.6%) |
| Mar 2005 | - | $217.56M(+3.0%) |
| Dec 2004 | $211.33M(+65.7%) | $211.33M(-21.8%) |
| Sep 2004 | - | $270.26M(+15.2%) |
| Jun 2004 | - | $234.66M(+33.7%) |
| Sep 2003 | - | $175.51M(+21.6%) |
| Jun 2003 | - | $144.34M(+21.3%) |
| Mar 2003 | - | $119.01M(+1.4%) |
| Dec 2002 | $127.51M(+118.8%) | - |
| Sep 2002 | - | $117.39M(+38.6%) |
| Jun 2002 | - | $84.71M(-37.4%) |
| Mar 2002 | - | $135.40M(+132.4%) |
| Dec 2001 | $58.27M(+75.9%) | $58.27M(-25.6%) |
| Sep 2001 | - | $78.30M(+175.6%) |
| Jun 2001 | - | $28.42M(-60.8%) |
| Mar 2001 | - | $72.40M(+118.5%) |
| Dec 2000 | $33.13M(-19.2%) | $33.13M(+18.3%) |
| Sep 2000 | - | $28.01M(+47.5%) |
| Jun 2000 | - | $18.99M(+2.9%) |
| Mar 2000 | - | $18.46M |
| Dec 1999 | $40.98M(+65.2%) | - |
| Dec 1998 | $24.81M | - |
FAQ
- What is Charles River Laboratories International, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. annual cash & cash equivalents year-on-year change?
- What is Charles River Laboratories International, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. quarterly cash & cash equivalents year-on-year change?
What is Charles River Laboratories International, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of CRL is $204.14M
What is the all-time high annual cash & cash equivalents for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high annual cash & cash equivalents is $282.57M
What is Charles River Laboratories International, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, CRL annual cash & cash equivalents has changed by -$78.43M (-27.76%)
What is Charles River Laboratories International, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CRL is $207.67M
What is the all-time high quarterly cash & cash equivalents for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high quarterly cash & cash equivalents is $470.45M
What is Charles River Laboratories International, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, CRL quarterly cash & cash equivalents has changed by -$2.82M (-1.34%)